ArticleInternational journal of clinical pediatric dentistry2025
Comparative Evaluation of Three Remineralization Agents-Bioactive Glass, Nanohydroxyapatite and Casein Phosphopeptide-amorphous Calcium Phosphate Fluoride-based Slurry on Enamel Erosion of Primary Teeth: An
Article in International journal of clinical pediatric dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Biomimetic Enamel Remineralization in Pediatric Dentistry: From Biological Principles to Clinical Evidence.Cureus · 2026Review
- Assessment of the remineralizing potential of nano-bioactive glass, nano-hydroxyapatite, and sodium fluoride on artificial carious lesions in primary teeth.BMC oral health · 2026Article
- Salivary proteins, proteases, and disease pathophysiology in oral health and precision diagnostics: a narrative review.Frontiers in dental medicine · 2026Review
- Emerging trends in enamel remineralization.Bioinformation · 2026Article
- Comparative Assessment of the Remineralization Potential of Five Modern Oral Health Products on Bovine Enamel.Journal of functional biomaterials · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims and background: To compare and evaluate the effects of bioactive glass (BAG), nano hydroxyapatite (nHAp), and casein phosphopeptide-amorphous calcium phosphate fluoride (CPP-ACPF)-based slurry on surface microhardness (SMH) of demineralized enamel. Materials and methods: Thirty-eight extracted deciduous teeth were disinfected in 5.25% sodium hypochlorite solution for 1 hour and stored in 1% thymol prior to specimen preparation. Each tooth was decoronated at the level of the cemento-enamel junction (CEJ), and the crown was sectioned mesiodistally into two halves using a diamond disc. The slurry was prepared by suspending the respective remineralizing agent. The solutions were thoroughly stirred using a magnetic stirrer for 1 minute at room temperature before starting the potential of hydrogen (pH)-cycling. The pH values of all solutions were monitored with a pH-sensitive electrode. After completion of all cycles, microhardness and surface evaluation were done using the Vickers hardness test and sent for scanning electron microscopy (SEM) analysis. Results: Data obtained were compiled, tabulated, and subjected to statistical analysis using IBM SPSS software version 23. ANOVA test and Conclusion: nHA had better potential to remineralize enamel. BAG, nHA, and CPP-ACPF enhanced the SMH values, thus can be considered effective for remineralization. Clinical significance: (1) Nano hydroxyapatite promotes remineralization of enamel and would be advantageous in the treatment of enamel erosion. (2) Bioactive glass, nHAp, and CPP-ACPF improve the SMH values, thus can be considered effective for remineralization. How to cite this article: Mareddy AR, Reddy VN, Done V,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.